Xiaokang Zhang Selected Research

Xiaokang Zhang Research Topics

Disease

19	Neoplasms (Cancer) 01/2024 - 01/2013
5	Infections 03/2024 - 04/2010
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 01/2012
4	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 01/2020
3	Oligodendroglioma 11/2023 - 01/2022
3	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2023 - 01/2012
3	Prostatic Neoplasms (Prostate Cancer) 12/2022 - 01/2021
3	Glioma (Gliomas) 10/2022 - 08/2022
2	Lymphoma (Lymphomas) 01/2024 - 01/2022
2	Hypertension (High Blood Pressure) 01/2023 - 01/2022
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 05/2021
2	Dengue (Dengue Fever) 01/2022 - 02/2015
2	Inflammation (Inflammations) 01/2022 - 01/2020
2	Atherosclerosis 01/2022 - 01/2020
2	Kidney Neoplasms (Kidney Cancer) 12/2021 - 01/2021
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2019 - 04/2015
1	Genetic Risk Score 01/2024
1	Cysts 11/2023
1	Acquired Immunodeficiency Syndrome (AIDS) 11/2023
1	Community-Acquired Infections 09/2023
1	Pneumonia (Pneumonitis) 09/2023
1	Cardiac Arrhythmias (Arrythmia) 06/2023
1	Pulmonary Hypertension 04/2023
1	Arteriosclerosis 01/2023
1	Disease Resistance 01/2023
1	Fusariosis 01/2023
1	Neoplasm Metastasis (Metastasis) 12/2022
1	Hyperplasia 04/2022
1	Congenital Abnormalities (Deformity) 02/2022
1	Coronary Disease (Coronary Heart Disease) 01/2022
1	Atherosclerotic Plaque (Atheroma) 01/2022
1	Type 2 Diabetes Mellitus (MODY) 01/2022
1	Down Syndrome (Down's Syndrome) 01/2022
1	Hyperlipidemias (Hyperlipidemia) 01/2022
1	Homocysteinemia 01/2022
1	Dysferlinopathy 01/2022
1	Virus Diseases (Viral Diseases) 01/2022
1	Hyperhomocysteinemia 01/2022

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 03/2024 - 04/2010
7	Biomarkers (Surrogate Marker)IBA 06/2023 - 04/2015
4	Chimeric Antigen ReceptorsIBA 01/2023 - 01/2019
3	Air Pollutants (Pollutants, Air)IBA 01/2023 - 01/2022
3	LipidsIBA 01/2023 - 01/2020
3	AntigensIBA 01/2023 - 01/2022
3	Messenger RNA (mRNA)IBA 01/2022 - 04/2015
2	Monoclonal AntibodiesIBA 01/2024 - 02/2015
2	Indicators and Reagents (Reagents)IBA 11/2023 - 03/2016
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 06/2023 - 01/2022
2	Particulate MatterIBA 01/2023 - 01/2022
2	CytokinesIBA 01/2023 - 12/2022
2	ErbB Receptors (EGF Receptor)IBA 10/2022 - 11/2019
2	Environmental Pollutants (Pollutants, Environmental)IBA 01/2022 - 01/2022
2	Folic Acid (Vitamin M)FDA LinkGeneric 01/2022 - 01/2022
2	Tyrosine Kinase InhibitorsIBA 12/2021 - 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2024
1	daratumumabIBA 01/2024
1	Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA 01/2024
1	AminoglycosidesIBA 11/2023
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2023
1	Gentamicins (Gentamicin)FDA LinkGeneric 09/2023
1	Polysaccharides (Glycans)IBA 09/2023
1	OzoneIBA 06/2023
1	Leucine (L-Leucine)FDA Link 01/2023
1	NucleotidesIBA 01/2023
1	Interleukin-15 (Interleukin 15)IBA 01/2023
1	Carbon MonoxideIBA 01/2023
1	Fungal ProteinsIBA 01/2023
1	ClaudinsIBA 01/2023
1	Circular RNAIBA 01/2023
1	Therapeutic UsesIBA 01/2023
1	Docetaxel (Taxotere)FDA Link 12/2022
1	factor EF-PIBA 10/2022
1	Heavy MetalsIBA 10/2022
1	Glial Fibrillary Acidic ProteinIBA 10/2022
1	AntioxidantsIBA 04/2022
1	CollagenIBA 04/2022
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 03/2022
1	Petroleum (Crude Oil)IBA 02/2022
1	5-Methylcytosine (5 Methylcytosine)IBA 01/2022
1	antineoplaston A10 (A 10)IBA 01/2022
1	HomocysteineIBA 01/2022
1	Lenalidomide (CC 5013)FDA Link 01/2022
1	Circulating Tumor DNAIBA 01/2022
1	DysferlinIBA 01/2022
1	Lipoproteins (Lipoprotein)IBA 01/2022
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2022
1	Sulfur DioxideIBA 01/2022
1	Cell Adhesion MoleculesIBA 01/2022
1	oxidized low density lipoproteinIBA 01/2022
1	Protein Isoforms (Isoforms)IBA 01/2022
1	orelabrutinibIBA 01/2022

Therapy/Procedure

4	Therapeutics 01/2023 - 03/2016
2	Chemoradiotherapy 11/2023 - 06/2023
2	Immunotherapy 12/2022 - 12/2021
2	Prostatectomy (Retropubic Prostatectomy) 12/2022 - 01/2022
1	Patient Admission (Patient Admissions) 01/2023
1	Drug Therapy (Chemotherapy) 12/2022
1	Radiotherapy 12/2022
1	Neurological Rehabilitation 10/2022
1	Precision Medicine 08/2022